{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T19:43:50Z","timestamp":1788637430165,"version":"build-2803163510"},"reference-count":18,"publisher":"FapUNIFESP (SciELO)","issue":"3A","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2002,9]]},"abstract":"<jats:p>Myasthenic crisis (MC) is a life-threatening complication of myasthenia gravis (MG) with a high mortality rate. The aim of our study was to review the different therapeutics approaches in the treatment of MC and their impact in the final outcome. We reviewed the medical files of patients diagnosed with MG admitted between February 1993 and October 1997, who developed MC. Sex, mean age, disease's duration, functional scale, symptoms preceding the crisis, crisis therapy in each set and mortality were then analysed. There were 24 patients who developed MC, 21 females and 3 males, with 1 neonatal, 1 congenital sporadic, 17 juvenile\/adult, 3 over 50 years and 2 with thymoma. Dysphagia, dysphonia and dysartria were the most common symptoms preceding the crisis. A precipitating factor was elicited in 8 cases and the most common was infection (upper airway infection, urinary tract infection and pneumonia). 16 patients needed a nasogastric tube and 9 had a tracheostomy performed. 24 patients used anticholinesterase drugs, 21 prednisone, 7 immunosuppressive agents, 5 plasmapheresis, 3 human hyperimune gamma immunoglobulin and 12 had thymectomy. A good response was obtained in 13, satisfactory in 7 and there were 4 deaths. We concluded that in spite of all the therapeutics options, there were non statistically significant differences in the outcome of patients that underwent thymectomy and those who did not.<\/jats:p>","DOI":"10.1590\/s0004-282x2002000400001","type":"journal-article","created":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T10:32:51Z","timestamp":1113561171000},"page":"519-526","source":"Crossref","is-referenced-by-count":17,"title":["Myasthenic crisis: report of 24 cases"],"prefix":"10.1590","volume":"60","author":[{"given":"Lineu Cesar","family":"Werneck","sequence":"first","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana Herminia","family":"Scola","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Manoel Branco","family":"Germiniani","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enio A.","family":"Comerlato","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Marcos Bezerra","family":"Cunha","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Myasthenia gravis","first-page":"2011","author":"Oosterhuis HJGH","year":"1984"},{"key":"ref2","first-page":"243","article-title":"Myasthenia gravis and myasthenic syndromes","volume":"12","author":"Sanders DB","year":"1994","journal-title":"Neurologic Clinics of North America"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/00003246-199707000-00027","article-title":"Therapy of myasthenic crisis","volume":"25","author":"Berrouschot J","year":"1997","journal-title":"Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/0090-3493","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s004150050141","article-title":"Long-term cyclosporine treatment in a group of severe myasthenia gravis patients","volume":"244","author":"Bonifati DM","year":"1997","journal-title":"J Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0340-5354","issn-type":"print"},{"key":"ref5","series-title":"Miastenia grave","first-page":"10","author":"Assis JM","year":"1990"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.48.5.1253","article-title":"Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation","volume":"48","author":"Thomas CE","year":"1997","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1590\/S0004-282X1999000300018","article-title":"Miastenia grave: avalia\u00e7\u00e3o cl\u00ednica de 153 pacientes","volume":"57","author":"Cunha FMB","year":"1999","journal-title":"Arq Neuropsiquiatr","ISSN":"https:\/\/id.crossref.org\/issn\/0004-282X","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archneur.1993.00540080046012","article-title":"Myasthenic crisis: response to plasmapheresis following failure of intravenous gamma globulin","volume":"50","author":"Stricker RB","year":"1993","journal-title":"Arch Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9942","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/00003246-199306000-00025","article-title":"Continuos infusion of pyridostigmine in the management of myasthenic crisis","volume":"21","author":"Saltis LM","year":"1993","journal-title":"Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/0090-3493","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/00007611-198510000-00017","article-title":"Treatment of myasthenic crisis in late life","volume":"78","author":"Sellman MS","year":"1985","journal-title":"South Med J","ISSN":"https:\/\/id.crossref.org\/issn\/0038-4348","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00003081-199103000-00012","article-title":"Myasthenia gravis in mothers and their newborns","volume":"34","author":"Plauch\u00ea WC","year":"1991","journal-title":"Clin Obstet Gynecol","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9201","issn-type":"print"},{"key":"ref12","first-page":"94:480","article-title":"Myasthenic crisis in the puerperium: the possible importance os alpha-fetoprotein: case report","author":"Hatada Y","year":"1987","journal-title":"Br J Obstet Gynaecol","ISSN":"https:\/\/id.crossref.org\/issn\/0306-5456","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.35.8.1219","article-title":"Myasthenic crisis after intravenous administration of iodinated contras agent","volume":"35","author":"Chagnac Y","year":"1985","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.36.3.444-b","article-title":"Myasthenic crisis precipitated by iodinated contrast agents","volume":"36","author":"Hilton-Jones D","year":"1986","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref15","first-page":"821","article-title":"Management of myasthenic crisis","volume":"21","author":"Borel CO","year":"1993","journal-title":"Continuous anticholinesterase infusions. Crit Care Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1590\/S0004-282X1987000400004","article-title":"Myasthenia grave: avalia\u00e7\u00e3o cl\u00ednica e terap\u00eautica de 55 casos","volume":"45","author":"Werneck LC","year":"1987","journal-title":"Arq Neuropsiquiatr","ISSN":"https:\/\/id.crossref.org\/issn\/0004-282X","issn-type":"print"},{"key":"ref17","first-page":"436","article-title":"The outcome of thymectomy in non thymomatous myasthenia gravis","volume":"166","author":"Huang MH","year":"1988","journal-title":"Surg Gynecol Obstet","ISSN":"https:\/\/id.crossref.org\/issn\/0039-6087","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1034\/j.1600-0404.2000.00014.x","article-title":"Myasthenia gravis: a retrospective study comparing thymectomy to conservative treatment","volume":"101","author":"Werneck LC","year":"2000","journal-title":"Acta Neurol Scand","ISSN":"https:\/\/id.crossref.org\/issn\/0001-6314","issn-type":"print"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v60n3a\/11118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T17:58:23Z","timestamp":1495648703000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2002000400001&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":18,"journal-issue":{"issue":"3A","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S0004-282X2002000400001"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x2002000400001","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}